News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Advancements in Oncology and Cancer Understanding – The Babak Lab
Photo taken from The Babak Lab/LinkedIn
Jul 7, 2024, 14:59

Advancements in Oncology and Cancer Understanding – The Babak Lab

The Babak Lab made the following post on LinkedIn:

“Weekly Digest Advancements in Oncology and Cancer Understanding

Stay informed about the latest advancements in cancer treatment and understanding to support yourself better, your loved ones, and your community with The Babak Lab.

  1. Pediatric Oncology Breakthrough: FDA Approves Lutathera for Adolescents
    A monumental approval expands treatment options for young patients with rare neuroendocrine tumors. Discover how this new FDA approval brings hope and improved outcomes for adolescents with GEP-NETs. Understand the importance of advancing personalized treatments in pediatric oncology.
  2. CAR T-Cell Therapy: Safe and Promising with Essential Monitoring
    Gain insights from a recent NEJM Group study that underscores the safety and effectiveness of CAR T-cell therapy while highlighting the importance of ongoing patient monitoring to enhance treatment outcomes.
  3. Understanding Cancer Staging: The TNM System Explained
    Learn how cancer stages are determined and what they mean for treatment and prognosis. This knowledge empowers patients and their families with essential information to navigate a cancer diagnosis.”

Source: The Babak Lab/LinkedIn

adolescents cancer Cancer Diagnosis Cancer Education cancer prognosis Cancer Staging cancer treatment cancer understanding CAR T-cell therapy FDA approval GEP-NETS Lutathera Maria Babak NEJM Group neuroendocrine tumors OncoDaily Oncology oncology advancements patient monitoring pediatric oncology personalized treatments The Babak Lab TNM system
Special Coverage
Blog
Dec 25, 2024, 21:46
Rafael Fonseca: Higher rate of neuropathy for bortezomib vs carfilzomib
Blog
Dec 25, 2024, 21:43
Rohit Gosain: Summary of 12 new indications in heme malignancies FDA in 2024
Blog
Dec 25, 2024, 20:38
Volunteering opportunity at Rehoboth Cancer Support Foundation for oncology nurses and doctors
Blog
Dec 25, 2024, 20:35
Gianrico Farrugia: This year, Mayo Clinic had the honor of caring for 1.3 million patients
Blog
Dec 25, 2024, 20:32
Jennifer Bires: Sexual health series for women who have been impacted by cancer by Inova
Blog
Dec 25, 2024, 20:30
A brighter future-one where we work together to end cancer, one discovery at a time - NFCR
Blog
Dec 25, 2024, 20:28
Amol Akhade: My wishlist from Santa Claus and from 2025 in oncology
Blog
Dec 25, 2024, 20:26
Jordan Johnson: Celebrating Partnership and Progress - Warm Wishes from Bridge Oncology this Holiday Season
Blog
Dec 25, 2024, 20:15
NEJM Group - The science behind a study of ponsegromab to treat cancer cachexia
Blog
Dec 25, 2024, 20:12
UICC is excited to welcome the Federation of Asian Organizations for Radiation Oncology - FARO to the UICC community
Blog
Dec 25, 2024, 20:05
Childhood Cancer International - Give the Gift of Life This Christmas: Support Children’s Cancer Treatment Around the World
Blog
Dec 25, 2024, 19:43
Looking back at the European Cancer Summit 2024 - European Cancer Organisation